Protocol for a randomised, double-masked, sham-controlled phase 4 study on the efficacy, safety and tolerability of intravitreal aflibercept monotherapy compared with aflibercept with adjunctive photodynamic therapy in polypoidal choroidal vasculopathy: the ATLANTIC study.
João Pedro MarquesCláudia FarinhaMiguel Ângelo CostaÂngela FerrãoSandrina NunesRufino SilvaPublished in: BMJ open (2017)
This study is registered under the EudraCT number: 2015-001368-20 and the ClinicalTrials.gov Identifier: NCT02495181.